Table 1. Characteristics of studies included in this meta-analysis.
Gene | Author | Year | Ethnicity | Country | Sample Size | Genotyping | Matching Criteria | MAF in | HWE | ||
Polymorphism | Reference | Case | Control | Methods | Case | Control | |||||
Arg194Trp | Huang [18] | 2007 | Asian | China | 539 | 800 | MA-PCR | Age,resident and medical history | 0.35 | 0.29 | Yes |
Farkasova [19] | 2008 | Caucasian | Slovakia | 17 | 30 | PCR-RFLP | _ | _ | _ | _ | |
Wang [23] | 2010 | Asian | China | 123 | 175 | PCR-RFLP | Age and medical history | 0.28 | 0.19 | Yes | |
Settheetham-Ishida [20] | 2011 | Asian | Thailand | 111 | 118 | PCR-RFLP | Medicalhistory | 0.30 | 0.23 | No | |
Barbisan [21] | 2011 | Latin America | Argentina | 103 | 114 | PCR-RFLP | Age | 0.14 | 0.09 | No | |
Arg280His | Huang [18] | 2007 | Asian | China | 539 | 800 | MA-PCR | Age, residentand medicalhistory | 0.12 | 0.12 | Yes |
Wang [23] | 2010 | Asian | China | 123 | 175 | PCR-RFLP | Age andmedical history | 0.14 | 0.10 | No | |
Arg399Glu | Niwa [17] | 2005 | Asian | Japan | 131 | 320 | PCR-RFLP | Age, medical history and smoking | 0.29 | 0.25 | Yes |
Huang [18] | 2007 | Asian | China | 539 | 800 | MA-PCR | Age, residentand medicalhistory | 0.28 | 0.19 | Yes | |
Hong [25] | 2008 | Asian | China | 72 | 176 | Taqman | Age, race, relationship, medical history and sex history | 0.26 | 0.22 | Yes | |
Farkasova [19] | 2008 | Caucasian | Slovakia | 18 | 30 | PCR-RFLP | _ | _ | _ | _ | |
Jiang [24] | 2009 | Asian | China | 436 | 503 | PCR-RFLP | Medical history | 0.27 | 0.27 | Yes | |
Xiao [26] | 2010 | Asian | China | 162 | 183 | PCR-RFLP | Age and medical history | 0.27 | 0.30 | Yes | |
Settheetham-Ishida [20] | 2011 | Asian | Thailand | 111 | 118 | PCR-RFLP | Medical history | 0.22 | 0.23 | Yes | |
Barbisan [21] | 2011 | Latin America | Argentina | 103 | 114 | PCR-RFLP | Age | 0.33 | 0.42 | Yes | |
Roszak [22] | 2011 | Caucasian | Poland | 189 | 308 | PCR-RFLP | Age | 0.47 | 0.37 | Yes |
PCR-RFLP, polymerase chain reaction - restriction fragment length polymorphism; MA-PCR, mismatch amplification - polymerase chain reaction; MAF, minor allele frequency; HWE, Hardy– Weinberg equilibrium in controls.